F. Tas Et Al. , "Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma," Asian Pacific journal of cancer prevention : APJCP , vol.18, pp.599-601, 2017
Tas, F. Et Al. 2017. Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma. Asian Pacific journal of cancer prevention : APJCP , vol.18 , 599-601.
Tas, F., Bilgin, E., Erturk, K., & Duranyıldız, D., (2017). Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma. Asian Pacific journal of cancer prevention : APJCP , vol.18, 599-601.
Tas, Faruk Et Al. "Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma," Asian Pacific journal of cancer prevention : APJCP , vol.18, 599-601, 2017
Tas, Faruk Et Al. "Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma." Asian Pacific journal of cancer prevention : APJCP , vol.18, pp.599-601, 2017
Tas, F. Et Al. (2017) . "Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma." Asian Pacific journal of cancer prevention : APJCP , vol.18, pp.599-601.
@article{article, author={Faruk TAŞ Et Al. }, title={Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma}, journal={Asian Pacific journal of cancer prevention : APJCP}, year=2017, pages={599-601} }